nference Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 336

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

nference General Information

Description

Developer of an artificial intelligence-based clinical data management platform designed to transform unstructured data captured in electronic medical records. The company's software utilizes neural networks for real-time and automated extraction of insights from real-world patient datasets and delivers comprehensive biological and clinical insights into patient care, enabling pharmaceutical, biotechnology, and healthcare enterprises to solve drug discovery and clinical research challenges.

Contact Information

Website
www.nference.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Main Street
  • Suite 400, East Arcade, 4th Floor
  • Cambridge, MA 02142
  • United States
+1 (781)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Big Data, SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • One Main Street
  • Suite 400, East Arcade, 4th Floor
  • Cambridge, MA 02142
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

nference Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-Dec-2022 Completed Generating Revenue
6. Later Stage VC (Series C) 04-Nov-2022 Completed Generating Revenue
5. Later Stage VC (Series C) 15-Dec-2020 Completed Generating Revenue
4. Accelerator/Incubator 29-Sep-2020 Completed Generating Revenue
3. Later Stage VC (Series B) 08-Jan-2020 Completed Generating Revenue
2. Later Stage VC (Series A) 06-Jun-2018 $12M $15M Completed Generating Revenue
1. Seed Round 10-Jan-2016 $3M $3M Completed Generating Revenue
To view nference’s complete valuation and funding history, request access »

nference Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B-1
Series B
Series A-1 205,480 $0.001000 $5.11 $5.11 1x $5.11 0.17%
Series A 3,105,591 $0.001000 $3.54 $3.54 1x $3.54 2.58%
To view nference’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

nference Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-based clinical data management platform designed to transform unstructured data
Discovery Tools (Healthcare)
Cambridge, MA
336 As of 2026

Paris, France
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

nference Competitors (18)

One of nference’s 18 competitors is Owkin, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Owkin Venture Capital-Backed Paris, France
Verana Health Venture Capital-Backed San Francisco, CA
BenevolentAI Formerly PE-Backed Luxembourg, Luxembourg
Partex.AI Venture Capital-Backed Eschborn, Germany
Flatiron Formerly VC-backed New York, NY
You’re viewing 5 of 18 competitors. Get the full list »

nference Patents

  • 149

    Total Documents Applications and Grants

  • Total Patents Families

  • 81

    Granted

  • 30

    Pending

  • Expiring in next 12 mo

nference Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12468954-B1 Apparatus and method for optimizing an operation using a deviation Active 04-Oct-2024
US-20260087172-A1 Systems and methods for deidentification of unstructured data using semi-structured elements Pending 20-Sep-2024
US-12229962-B1 Apparatus and method for leveraging a repository of images containing implant devices in a human body Active 19-Aug-2024
US-20260051063-A1 Apparatus and method for leveraging a repository of images containing implant devices in a human body Pending 19-Aug-2024
WO-2026043832-A1 Apparatus and method for leveraging a repository of images containing implant devices in a human body Pending 19-Aug-2024 G06T7/0016
To view nference’s complete patent history, request access »

nference Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

nference Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
PharmStars Accelerator/Incubator
A&E Investments Venture Capital Minority
AI Venture Labs Accelerator/Incubator Minority
Mayo Clinic Ventures Corporate Venture Capital Minority
NTTVC Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

nference Investments & Acquisitions (4)

nference’s most recent deal was a Merger/Acquisition with Predible Health. The deal was made on 11-May-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Predible Health 11-May-2022 Merger/Acquisition Decision/Risk Analysis
Anumana 14-Apr-2021 Joint Venture Decision/Risk Analysis
Spectral Insights 01-Apr-2020 Merger/Acquisition Business/Productivity Software
Qrativ 14-Jul-2017 Joint Venture Drug Discovery
To view nference’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

nference FAQs

  • When was nference founded?

    nference was founded in 2013.

  • Where is nference headquartered?

    nference is headquartered in Cambridge, MA.

  • What is the size of nference?

    nference has 336 total employees.

  • What industry is nference in?

    nference’s primary industry is Discovery Tools (Healthcare).

  • Is nference a private or public company?

    nference is a Private company.

  • What is nference’s current revenue?

    The current revenue for nference is .

  • How much funding has nference raised over time?

    nference has raised $148M.

  • Who are nference’s investors?

    PharmStars, A&E Investments, AI Venture Labs, Mayo Clinic Ventures, and NTTVC are 5 of 7 investors who have invested in nference.

  • Who are nference’s competitors?

    Owkin, Verana Health, BenevolentAI, Partex.AI, and Flatiron are some of the 18 competitors of nference.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process